现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
18期
2627-2629,2630
,共4页
陈坚%裴峰%高巍然%魏燕%孔祥军%瞿琴%吴俊兰
陳堅%裴峰%高巍然%魏燕%孔祥軍%瞿琴%吳俊蘭
진견%배봉%고외연%위연%공상군%구금%오준란
胰腺恶性肿瘤%高强度聚焦超声%替吉奥
胰腺噁性腫瘤%高彊度聚焦超聲%替吉奧
이선악성종류%고강도취초초성%체길오
pancreatic carcinoma%high -intensity focused ultrasound%S -1
目的:探讨高强度聚焦超声肿瘤消融与口服替吉奥联合治疗晚期胰腺癌的疗效。方法:将43例晚期胰腺癌患者随机分为高强度聚焦超声治疗组和高强度聚焦超声+替吉奥治疗组,观察不良反应和疗效。结果:高强度聚焦超声、高强度聚焦超声+替吉奥的近期有效率分别为:22.73%(5/22)和52.38%(11/21),联合治疗的效果明显优于单纯治疗(P <0.05);临床获益反应率分别为81.82%(18/22)和76.19%(16/21),两组无明显差异(P >0.05);不良反应方面,接受高强度聚焦超声治疗的患者明显少于联合使用替吉奥的患者(P <0.05);中位生存期分别为7.6和13.6个月,接受联合使用替吉奥治疗的患者生存期明显优于仅接受高强度聚焦超声治疗的患者(P <0.05)。结论:在高强度聚焦超声治疗的基础上,联合口服替吉奥治疗晚期胰腺癌患者治疗效果更好。
目的:探討高彊度聚焦超聲腫瘤消融與口服替吉奧聯閤治療晚期胰腺癌的療效。方法:將43例晚期胰腺癌患者隨機分為高彊度聚焦超聲治療組和高彊度聚焦超聲+替吉奧治療組,觀察不良反應和療效。結果:高彊度聚焦超聲、高彊度聚焦超聲+替吉奧的近期有效率分彆為:22.73%(5/22)和52.38%(11/21),聯閤治療的效果明顯優于單純治療(P <0.05);臨床穫益反應率分彆為81.82%(18/22)和76.19%(16/21),兩組無明顯差異(P >0.05);不良反應方麵,接受高彊度聚焦超聲治療的患者明顯少于聯閤使用替吉奧的患者(P <0.05);中位生存期分彆為7.6和13.6箇月,接受聯閤使用替吉奧治療的患者生存期明顯優于僅接受高彊度聚焦超聲治療的患者(P <0.05)。結論:在高彊度聚焦超聲治療的基礎上,聯閤口服替吉奧治療晚期胰腺癌患者治療效果更好。
목적:탐토고강도취초초성종류소융여구복체길오연합치료만기이선암적료효。방법:장43례만기이선암환자수궤분위고강도취초초성치료조화고강도취초초성+체길오치료조,관찰불량반응화료효。결과:고강도취초초성、고강도취초초성+체길오적근기유효솔분별위:22.73%(5/22)화52.38%(11/21),연합치료적효과명현우우단순치료(P <0.05);림상획익반응솔분별위81.82%(18/22)화76.19%(16/21),량조무명현차이(P >0.05);불량반응방면,접수고강도취초초성치료적환자명현소우연합사용체길오적환자(P <0.05);중위생존기분별위7.6화13.6개월,접수연합사용체길오치료적환자생존기명현우우부접수고강도취초초성치료적환자(P <0.05)。결론:재고강도취초초성치료적기출상,연합구복체길오치료만기이선암환자치료효과경호。
Objective:To investigate the effect of high -intensity focused ultrasound with S -1 treatment on ad-vanced pancreatic cancer.Methods:All 43 patients with advanced pancreatic cancer were randomly divided into high-intensity focused ultrasound(HF)group and high -intensity focused ultrasound +S -1(HS)group.Results:The response rates and HS group respectively were 22.73%(5 /22)and 52.38%(11 /21).The effect of combination ther-apy was better than the unitary treatment (P <0.05).Clinical benefit response rates respectively were 81.82%(18 /22)and 76.19%(16 /21),there was no significant difference between the groups (P >0.05).In toxicity,the HF group was lighter than HS group (P<0.05).The median survival time oftwo groups were 7.6 months and 13.6 months,the sur-vival of patients receiving combination therapy was significantly better than patients treated with monotherapy alone (P <0.05).Conclusion:On the based of high -intensity focused ultrasound therapy,combined with oral S -1 is better treatment of advanced pancreatic cancer patients.